Cellular actions of etretinate in psoriasis: Enhanced epidermal differentiation and reduced cell mediated inflammation are unexpected outcomes

Journal of Cutaneous Pathology

Volumn 23, Issue 5, 1996, Pages 404-418

  Gottlieb, Scott L ^a   Hayes, Elizabeth ^a   Gilleaudeau, Patricia ^a   Cardinale, Irma ^a   Gottlieb, Alice B ^b   Krueger, James G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; ETRETINATE; FILAGGRIN; HLA DR ANTIGEN; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; KERATIN; KERATOHYALIN; LIPID; RETINOID;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; PSORIASIS; PSORIASIS VULGARIS; PUVA; SKIN BIOPSY; SKINFOLD THICKNESS; STRATUM CORNEUM; T LYMPHOCYTE SUBPOPULATION;

CELL DIFFERENTIATION; EPITHELIUM; ETRETINATE; FEMALE; HUMANS; IMMUNITY, CELLULAR; INFLAMMATION; KERATINOCYTES; MALE; PSORIASIS;

EID: 0029955912     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1996.tb01430.x     Document Type: Article

References (41)

1. Rosenbach T, Czarnetzki BM. Retinoids. In: Dubertret L. ed. Psoriasis. Brescia, Italy: ISED Publishing Co., 1994: 151.
2. Gottlieb AB, Krueger JG. Role of T-lymphocytes. In: Dubertret L, ed. Psoriasis. Brescia, Italy: ISED Publishing Co, 1994: 63.
3. 380IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Medicine 1995: 1: 442.
4. Paukkonen K, Naukkarinen A, Horsmanheimo M. The development of manifest psoriatic lesions is linked with the invasion of CD8+ T cells and CD11c+ macrophages into the epidermis. Arch Dermatol Res 1992: 284: 375.
5. Prinz JC, Gross B, Vollmer S, et al. T cell clones from psoriasis skin lesions can promote keratinocyte proliferation in vitro via secreted products. Eur J Immunol 1994: 24: 593.
6. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. J Clin Invest 1995: 95: 317.
7. Vallat VP, Gilleaudeau P, Battat L, et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy. J Exp Med 1994: 180: 283.
8. Krueger JG, Wolfe JT, Nabeya RT, et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995: 182: 2057.
9. Gottlieb AB, Grossman RM, Khandke L, et al. Studies of the effect of cyclosporine in psoriasis in vivo: Combined effects on activated T lymphocytes and epidermal regenerative maturation. J Invest Dermatol 1992: 98: 302.
10. Mansbridge JN, Knapp AM. Changes in keratinocyte maturation during wound healing. J Invest Dermatol 1987: 89: 253.
11. Fisher GJ, Esmann J, Griffiths CEM, et al. Cellular, immunologic and biochemical characterization of topical retinoic acid-treated human skin. J Invest Dermatol 1991: 96: 699.
12. Lutzow-Holm C, De Angelis P, Clausen OPF. Retinoic acid provokes a regeneration-like proliferative response in murine epidermis. Arch Dermatol Res 1992: 284: 418.
13. Ross AC, Haemmerling UG. Retinoids and the immune system. In: Sporn MB, Roberts AB, Goodman DS. eds. The retinoids: biology, chemistry, and medicine. New York: Raven Press Ltd., 1994: 521.
14. Turpin J, Mehta K, Blick M, Hester JP, Lopez-Berestein G. Effect of retinoids on the release and gene expression of tumor necrosis factor-α in human peripheral blood monocytes. J Leukoc Biol 1990: 48: 444.
15. Majewski S, Wolska H, Jablonska S, Wasik M. Effects of systemic etretinate treatment on natural cytotoxicity, immune angiogenesis and neutrophil adherence in patients with various forms of psoriasis. Arch Imnumol Ther Exp 1989: 37: 459.
16. Fulton RA, Souteyrand P, Thivolet J. Influence of retinoid Ro 10-9359 on cell-mediated immunity in vivo. Dermatologica 1982: 165: 568.
17. Gollnick H, Bauer R, Brindley C, et al. Acitretin versus etretinate in psoriasis. J Am Acad Dermatol 1988: 19: 458.
18. Fowler SD, Greenspan P. Application of nile red, a red fluorescent hydrophorbic probe, for the detection of neutral lipid deposits in tissue sections: comparison with oil red O. J Histochem Cytochem 1985: 33: 833.
19. Krueger JG, Lin AN, Leong I, Carter DM. Junctional epidermolysis bullosa keratinocytes in culture display adhesive, structural, and functional abnormalities. J Invest Dermatol 1991: 97: 849.
20. Vallat VP, Gilleaudeau P, Battat L, et al. PUVA bath therapy with 8-methoxypsoralen. In: Weinstein G, Gottlieb AB. eds. Therapy of moderate-to-severe psoriasis. Portland, OR: National Psoriasis Foundation. 1993: 39.
21. Bos JD, Hagenaars C, Das PK, Krieg SR, Voorn WJ, Kapsenberg ML. Predominance of "memory" T cells (CD4+, CDw20+) over "naive" T cells (CD4+, CD45R+) in both normal and discased skin. Arch Dermatol Res 1989: 281: 24.
22. Wolfe J, Nabeya R, Vallat VP, et al. Is psoriasis primarily a disorder of epidermal CD4/CD8 T lymphocytes and epidermal regenerative activation? J Invest Dermatol 1993: (Abstract)
23. Lu I, Gilleaudeau P, McLane JA, et al. Modulation of epidermal differentiation, tissue inflammation, and T-lymphocyte infiltration in psoriatic plaques by topical calcitriol. J Am Acad Dermatol 1995 (submitted).
24. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol 1991: 127: 871.
25. Krueger JG, Gottlieb AB. Growth factors, cytokines and eicosanoids. In: Dubertret L. ed. Psoriasis. Brescia, Italy: ISED Publishing Co., 1994: 18.
26. Weinstein GD, Krueger JG. An overview of psoriasis. In: Weinstein GD, Gottlieb AB, eds. Therapy of moderate-to-severe psoriasis. Portland, OR: National Psoriasis Foundation, 1993: 1.
27. Gottlieb AB, Khandke L, Krane JF, et al. Anthralin decreases keratinocyte TGF-α expression and EGF-receptor binding in vitro. J Invest Dermatol 1992: 98: 680.
28. Darmon M, Blumenberg M. Retinoic acid in epithelial and epidermal differentiation. In: Darmon M, Blumenberg M. eds. Molecular biology of the skin. The Keratinocyte. San Diego [et al.]: Academic Press, Inc., 1993: 181.
29. Peck GL, DiGiovanna JJ. Synthetic retinoids in dermatology. In: Sporn MB, Roberts AB, Goodman DS. eds. The retinoids: biology, chemistry, and medicine. New York: Raven Press Ltd., 1994: 631.
30. Regnier M, Darmon M. Effect of retinoic acid on epidermal differentiation studied in the reconstructed skin model. In: Reichert U, Shroot B. eds. Pharmacology of retinoids in the skin. Basel: Karger, 1989: III:84.
31. Roop DR, Chung S, Cheng CK, et al. Epidermal differentiation and its modulation by retinoids. In: Reichert U, Shroot B. eds. Pharmacology of retinoids in the skin. Basel: Karger, 1989: III: 1.
32. Laugier J-P, Surber C, Bun H, et al. Determination of acitretin in the skin, in the suction blister, and in plasma of human volunteers after multiple oral dosing. J Pharm Sci 1994: 83: 623.
33. Anderson RR, Parrish JA. The optics of human skin. J Invest Dermatol 1981: 77: 13.
34. Petzelbauer P, Stingl G., Wolff K, Volc-Platzer B. Cyclosporin A suppresses ICAM- 1 expression by papillary endothelium in healing psoriatic plaques. J Invest Dermatol 1991: 96: 362.
35. Woodworth TG, Faherty D. Retinoids as potential therapeutics for rheumatic diseases. In: Lewis AJ, Doherty NS, Ackerman NR. eds. Therapeutic approaches to inflammatory diseases. New York: Elsevier Publishing Co., Inc., 1989: 198.
36. Chang JCC, Smith LR, Froning KJ, et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor Vβ3 and/ or Vβ13.1 genes. Proc Natl Acad Sci USA 1994: 91: 9282.
37. Ellis CN, Kang S, Grekin RC, LoBuglio AF, Voorhees JJ. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes. Arch Dermatol 1994: 121: 877.
38. Pigatto PD, Riva F, Altomare GF, Brugo AM, Morandotti A, Finzi AF. Efffect of etretinate on chemotaxis of neutrophils from patients with pustular and vulgar psoriasis. J Invest Dermatol 1983: 81: 418.
39. Orfanos CE, Bauer R. Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience. Br J Dermatol 1983: 109 (suppl 25): 55.
40. Dubertret L, Lebreton C. Neutrophil functions in vivo on human skin. Psoriasis and anti-inflammatory drug studies. Pathologie Biologie 1987: 35: 1389.
41. Ney UM, Ball IJ, Hill RP, Westmacott D, Bloxham DP. Anti-inflammatory effects of synthetic retinoids may be related to their immunomodulatory action. Dermatologica 1987: 175 (suppl 1): 93.